1. Pink Sheet

US FDA Chief Scientist Bumpus Will Become Principal Deputy Commissioner

 
• By Derrick Gingery

When Janet Woodcock retires early next year, Namandjé Bumpus will take over as No. 2 in command at the FDA. Since joining the agency in 2022 from Johns Hopkins, her profolio has included health disparities, cosmetics, and drug review disputes.

leadership promotion
Namandjé Bumpus will help complete the reorganization of the FDA's Human Foods Program and ORA. • Source: Shutterstock

The plan to replace Janet Woodcock’s substantial presence at the US Food and Drug Administration is beginning to take shape.

FDA Commissioner Robert Califf on 29 November announced that agency Chief Scientist Namandjé Bumpus would become principal deputy

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from US FDA

More from Agency Leadership